Novartis Returns US Rights to Advair, Easing Glaxo Threat - BusinessWeek
Posted by admin! / Under Drug Allergy
Novartis Returns US Rights to Advair, Easing Glaxo Threat BusinessWeek March 18 (Bloomberg) -- Novartis AG returned US development rights to a generic version of an asthma drug to UK partner Vectura Group Plc, ... |
Published on Thursday 18th of March 2010 11:37:04 AM



